US Stock MarketDetailed Quotes

Sionna Therapeutics (SION)

Watchlist
  • 38.850
  • -2.330-5.66%
Close Jan 15 16:00 ET
  • 38.850
  • 0.0000.00%
Post 16:10 ET
1.73BMarket Cap-24.43P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sionna Therapeutics (SION) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-14.93%23.81M
94.00%21.91M
49.53%19.66M
40.18%70.56M
43.97%18.13M
27.98M
11.29M
13.15M
21.66%50.33M
12.6M
Selling and administrative expenses
140.25%7.24M
126.49%6.05M
117.10%5.56M
36.68%13.27M
85.73%5.02M
--3.01M
--2.67M
--2.56M
43.45%9.71M
--2.71M
-General and administrative expense
140.25%7.24M
126.49%6.05M
117.10%5.56M
36.68%13.27M
85.73%5.02M
--3.01M
--2.67M
--2.56M
43.45%9.71M
--2.71M
Research and development costs
-34.73%16.04M
86.85%15.38M
33.74%13.67M
41.01%57.29M
44.12%14.25M
--24.58M
--8.23M
--10.22M
17.40%40.63M
--9.89M
Depreciation amortization depletion
34.02%520K
22.56%478K
17.76%431K
----
----
--388K
--390K
--366K
----
----
-Depreciation and amortization
34.02%520K
22.56%478K
17.76%431K
----
----
--388K
--390K
--366K
----
----
Operating profit
14.93%-23.81M
-94.00%-21.91M
-49.53%-19.66M
-40.18%-70.56M
-43.97%-18.13M
-27.98M
-11.29M
-13.15M
-21.66%-50.33M
-12.6M
Net non-operating interest income expense
46.88%3.46M
42.91%3.67M
165.02%3M
195.05%8.17M
283.18%2.12M
2.35M
2.57M
1.13M
144.61%2.77M
553K
Non-operating interest income
46.88%3.46M
42.91%3.67M
165.02%3M
195.05%8.17M
283.18%2.12M
--2.35M
--2.57M
--1.13M
144.61%2.77M
--553K
Other net income (expense)
-62.63%71K
-1.72%171K
5.36%177K
131.89%698K
0.00%166K
190K
174K
168K
301K
166K
Other non- operating income (expenses)
-62.63%71K
-1.72%171K
5.36%177K
131.89%698K
0.00%166K
--190K
--174K
--168K
--301K
--166K
Income before tax
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
-25.44M
-8.55M
-11.85M
-17.45%-47.26M
-11.88M
Income tax
Net income
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
-25.44M
-8.55M
-11.85M
-17.45%-47.26M
-11.88M
Net income continuous Operations
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
---25.44M
---8.55M
---11.85M
-17.45%-47.26M
---11.88M
Minority interest income
Net income attributable to the parent company
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
-25.44M
-8.55M
-11.85M
-17.45%-47.26M
-11.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
-25.44M
-8.55M
-11.85M
-17.45%-47.26M
-11.88M
Basic earnings per share
23.26%-0.46
-103.49%-0.41
-45.47%-0.62
14.52%-1.4534
12.61%-0.3734
-0.5994
-0.2015
-0.4262
26.76%-1.7003
-0.4272
Diluted earnings per share
23.26%-0.46
-103.49%-0.41
-45.47%-0.62
14.52%-1.4534
12.61%-0.3734
-0.5994
-0.2015
-0.4262
26.76%-1.7003
-0.4272
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -14.93%23.81M94.00%21.91M49.53%19.66M40.18%70.56M43.97%18.13M27.98M11.29M13.15M21.66%50.33M12.6M
Selling and administrative expenses 140.25%7.24M126.49%6.05M117.10%5.56M36.68%13.27M85.73%5.02M--3.01M--2.67M--2.56M43.45%9.71M--2.71M
-General and administrative expense 140.25%7.24M126.49%6.05M117.10%5.56M36.68%13.27M85.73%5.02M--3.01M--2.67M--2.56M43.45%9.71M--2.71M
Research and development costs -34.73%16.04M86.85%15.38M33.74%13.67M41.01%57.29M44.12%14.25M--24.58M--8.23M--10.22M17.40%40.63M--9.89M
Depreciation amortization depletion 34.02%520K22.56%478K17.76%431K----------388K--390K--366K--------
-Depreciation and amortization 34.02%520K22.56%478K17.76%431K----------388K--390K--366K--------
Operating profit 14.93%-23.81M-94.00%-21.91M-49.53%-19.66M-40.18%-70.56M-43.97%-18.13M-27.98M-11.29M-13.15M-21.66%-50.33M-12.6M
Net non-operating interest income expense 46.88%3.46M42.91%3.67M165.02%3M195.05%8.17M283.18%2.12M2.35M2.57M1.13M144.61%2.77M553K
Non-operating interest income 46.88%3.46M42.91%3.67M165.02%3M195.05%8.17M283.18%2.12M--2.35M--2.57M--1.13M144.61%2.77M--553K
Other net income (expense) -62.63%71K-1.72%171K5.36%177K131.89%698K0.00%166K190K174K168K301K166K
Other non- operating income (expenses) -62.63%71K-1.72%171K5.36%177K131.89%698K0.00%166K--190K--174K--168K--301K--166K
Income before tax 20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M-25.44M-8.55M-11.85M-17.45%-47.26M-11.88M
Income tax
Net income 20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M-25.44M-8.55M-11.85M-17.45%-47.26M-11.88M
Net income continuous Operations 20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M---25.44M---8.55M---11.85M-17.45%-47.26M---11.88M
Minority interest income
Net income attributable to the parent company 20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M-25.44M-8.55M-11.85M-17.45%-47.26M-11.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M-25.44M-8.55M-11.85M-17.45%-47.26M-11.88M
Basic earnings per share 23.26%-0.46-103.49%-0.41-45.47%-0.6214.52%-1.453412.61%-0.3734-0.5994-0.2015-0.426226.76%-1.7003-0.4272
Diluted earnings per share 23.26%-0.46-103.49%-0.41-45.47%-0.6214.52%-1.453412.61%-0.3734-0.5994-0.2015-0.426226.76%-1.7003-0.4272
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -